Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Label_Title

Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Socio-professional Profile of Individuals Living with Human Immunodeficiency Virus Who Tested Positive for HBsAg At the Laboratory of the Regional Hospital of Faranah, Guinea, 2022

Aïssatou Boiro*, Ousmane Camara, Ibrahima Sory Sow, Mariama Diallo, Thierno Amadou Labé Baldé, Mamadou Ciré Diallo, Mamadou Boundoukhoura Bah, Sanaba Boumbaly, Mohamed Sahar Traoré

Microbiologie, Guinea Institute for Applied Biology Research (IRBAG), Kindia, Republic of Guinea

Abstract: Co-infection with Human Immunodeficiency Virus (HIV) and Hepatitis B Surface Antigen (HBsAg) is a major public health challenge, particularly in sub-Saharan Africa. Knowledge of the socio-professional profiles of the individuals concerned is essential to strengthen appropriate prevention and treatment strategies. This study aimed to estimate the frequency of hepatitis B among people living with HIV at the Faranah Regional Hospital in 2022 and to identify the socio-professional factors associated with this co-infection. A cross-sectional study was conducted among 158 people living with HIV who were seen at the laboratory of the Faranah Regional Hospital between October and December 2022. We used the ‘SD-Bio line AgHBs’ immunochromatographic test for analysis. The data showed a seroprevalence of 18.82% for HIV/HBV co-infection, with a 95% confidence interval (CI): 12.82% - 25.02%. The median age was 32 years with an interquartile range of 17 years. Among the study population, women were the most co-infected (21.4%); the age group (adolescents, young people and adults) was the most affected with a rate of 93.3%; unmarried people predominated over married people with 60%; artisans and traders represented 63.3%. This study has enabled us to highlight the high prevalence of HIV/HBV co-infection and to understand the profiles of people living with HIV in Faranah. It would be crucial to implement effective diagnostic strategies in order to improve the quality of life of PLHIV in the Republic of Guinea.

Keywords: PLHIV, HBsAg, Socio-professional characteristics, Faranah, Guinea

Received January 21, 2026; Revised February 23, 2026; Accepted March 02, 2026

Citation: Aïssatou Boiro, Ousmane Camara, Ibrahima Sory Sow, Mariama Diallo, Thierno Amadou Labé Baldé, Mamadou Ciré Diallo, Mamadou Boundoukhoura Bah, Sanaba Boumbaly, Mohamed Sahar Traoré, Socio-professional Profile of Individuals Living with Human Immunodeficiency Virus Who Tested Positive for HBsAg At the Laboratory of the Regional Hospital of Faranah, Guinea, 2022. Journal of Applied & Environmental Microbiology, 14 (1). 9-13. January 2026. doi:10.12691/jaem-14-1-2

1. Introduction

Hepatitis B virus is a global public health problem. Approximately 254 million people are chronically infected with hepatitis B virus and are therefore at risk of developing liver cirrhosis and hepatocellular carcinoma [1].

Hepatitis B virus infection is effectively prevented by vaccination. HIV remains an important transmissible disease worldwide, contributing to significant morbidity and deaths each year [2]. HIV increases HBV chronicity rates, prolongs HBV circulation and increases liver-related morbidity [3]. Co-infection with hepatitis B virus is observed in approximately 7-10% of HIV-infected patients [4]. These infections share the same modes of transmission, including parenteral, sexual and mother-to-foetus, suggesting a high risk of co-infection with both viruses in the same patient [3,5].

Knowledge of this co-infection is essential for the monitoring and treatment of patients in order to reduce the risk of mortality in people living with HIV. HBV infection can complicate the treatment of immunocompromised individuals undergoing antiretroviral therapy. It is associated with an increase in liver diseases such as cirrhosis and hepatocellular carcinoma and can cause HIV infection to progress to AIDS and then to death [6]. Progression is approximately twice as likely in co-infected patients as in mono-infected patients [7].

In sub-Saharan Africa, the prevalence of HIV/HBV co-infection varies between 10 and 20% in West and Central Africa [8]. The progression of HBV infection to the chronic phase in this region is estimated at over 10%. This increases the risk of progression to end-stage liver disease [9].

In the Central African Republic, a survey conducted at the Sino-Central African Friendship Hospital in Bangui revealed a 7.7% prevalence of HIV/HBV co-infection [10]. In Senegal, a study conducted in 2021 among PLHIV in urban areas showed a prevalence of HIV/HBV co-infection of 12.4% [11]. In Burkina Faso, a prevalence of 12.86% of HIV/HBV co-infection was observed in an association providing medical care in the city of Ouagadougou in 2016 [12].

Despite international recommendations, systematic diagnosis of hepatitis B remains insufficient, highlighting an urgent need to improve screening and awareness practices [11].

In the Republic of Guinea, little data is available on HIV/HBV co-infection. Studies conducted among PLHIV in the haematology department of the Ignace Deen National Hospital and the Sino-Guinean Friendship Hospital showed prevalences of 8.49% [8] and 2.3% [13] of HIV/HBV co-infection, respectively. Similarly, another study conducted at the N'Zérékoré Regional Hospital among blood donors reported a 0.2% prevalence of HIV/HBV co-infection [14].

In the Faranah region, despite the health context marked by an estimated HIV prevalence of 1.2% in 2018 [15] among adults, data on HIV/HBV co-infection remains very limited. This makes it difficult to understand the extent of the problem in this region.

The challenges facing the Guinean health system, such as limited access to care, inadequate screening and treatment infrastructure, and insufficient awareness-raising among at-risk populations, highlight the need for research on this topic.

The objective of this study was to determine the prevalence of hepatitis B among people living with HIV at the Faranah Regional Hospital and to identify associated factors, in order to contribute to a better understanding of HIV/HBV co-infection.

2. Methodology

2.1. Study Design and Setting

A cross-sectional study was conducted from 1 January to 31 December 2022 to estimate the prevalence of hepatitis B among patients living with HIV treated at Faranah Regional Hospital (HRF). The laboratory at Faranah Regional Hospital served as the study setting. Faranah Regional Hospital (HRF), located in downtown Faranah in the market district, is a facility with a threefold mission: care, research and training. Under the authority of the Ministry of Health and Public Hygiene of the Republic of Guinea, it enjoys legal personality, financial autonomy and management autonomy in accordance with the laws and regulations governing public and administrative institutions (Article 2 of Decree 98/055/PRG/SGG).

2.2. Study Population and Sample Size

During the data collection period, all PLHIV aged 18 years and older who did not know their hepatitis B serological status and who freely agreed to participate in the study were systematically considered eligible. A total of 158 participants were selected during the study period.

2.3. Data Collection and Laboratory Analysis Procedures

After obtaining informed consent, an electronic questionnaire designed on KoboCollect was used. The data collected related to the socio-professional characteristics of the patients, including age, gender, marital status and occupation. Participants were also asked to provide a venous blood sample.

The SD-Bioline immunochromatographic test was used for analysis, in accordance with the manufacturer's instructions. After removing the cassette from its pouch, 100µl of blood serum was placed in the sample compartment, avoiding the formation of air bubbles. Depending on the concentration of anti-HBs antibodies in the sample, the test can react within 5 minutes.

The result is considered negative if only one line appears in the C zone, indicating that hepatitis B surface antibodies are absent.

The result is positive if both the test line (T) and the control line (C) appear, indicating that hepatitis B surface antibodies are present in the sample. Even if the concentration of hepatitis B antibodies is low, the sample will cause a faint colour to appear in the T zone. The result is invalid if the control line (T) does not appear. Results should be read and interpreted within 15 to 20 minutes.

2.4. Statistical Analysis of Data

Categorical variables were summarised as absolute frequencies and percentages, and quantitative variables were described in terms of median and interquartile range. Bivariate statistical analyses (Chi2 test or Fisher's exact test) were used to compare the proportions of PLHIV status with HBsAg with their socio-professional characteristics (P-value < 0.05 indicates a significant dependence). The distribution of HIV/HBV co-infection among HIV-positive individuals according to their socio-professional characteristics was represented as a horizontal bar chart. R 4.2.2 software was used to process and analyse the data.

2.5. Ethical Considerations

This study was conducted in accordance with ethical standards approved by Guinea's National Scientific Research Committee (Minutes No. 129/CNERS/16, 31 August 2015). Informed consent was obtained from all participants prior to their inclusion in the study. The confidentiality of the information obtained from participants was guaranteed.

3. Results

Socio-demographic characteristics of participants

Table 1. Socio-demographic characteristics of HBsAg-positive PLHIV received at the laboratory of the Regional Hospital of Faranah, Guinea 2022

A total of 158 people living with HIV were included in the study and were divided according to socio-demographic characteristics (Table 1). Among them, 56 were women and 102 were men (35.4% and 64.6% respectively). The median age was 32 years with an interquartile range of 17 years. Adolescents, young people and adults were the most represented (140; 88.6%). The population consisted mainly of unmarried people (72.8%) and married people (27.2%). Craftsmen and traders (56.3%) and housewives (24.1%) constituted the largest socio-professional group.

Table 2. Distribution of HIV/HBV co-infection among HIV-positive individuals according to their socio-professional characteristics

The frequency of hepatitis B co-infection among PLHIV was 18.82% with a 95% confidence interval (CI): 12.82% - 25.02%. It varies according to socio-professional characteristics (Figure 1). Women living with HIV were the most co-infected with hepatitis B (21.4%). Adolescents, young people and adults have an HIV/HBV co-infection rate of 20%, and older people have the lowest rate (11.1%). Among the study population, married individuals were the most exposed (27.9%). However, the most at-risk occupation was that of artisans and traders (21.3%), followed by executives (18.2%).

Table 3. Factors associated with HBsAg in people living with HIV

The results on factors associated with hepatitis B co-infection in people living with HIV (PLHIV) are presented in Table 2. With regard to HIV/HBV co-infection, this analysis shows that there is no significant difference between men and women (p-value = 0.6) or between age groups (p-value = 0.5). However, marital status has a significant effect on HIV/HBV co-infection, with married individuals having a significantly lower risk than unmarried individuals (p-value = 0.0080). Furthermore, there is a trend towards a higher, but not significant, risk among PLHIV who are artisans and traders.

4. Discussion

HIV/HBV co-infection is a major public health issue, particularly in regions where both infections are common. This phenomenon presents particular challenges in terms of treatment and improving patient health.

This study aims to examine the socio-professional profile of PLHIV co-infected with hepatitis B at the Faranah Regional Hospital, highlighting patient characteristics and the implications of these observations for public health.

In this study, a seroprevalence of 19% for HBsAg among PLHIV was observed. This rate differs from the results of previous studies conducted in the haematology department of Ignace Deen National Hospital, which found a prevalence of HIV/HBV co-infection of 8.49% [8], 9.17% at Donka Day Hospital [16] and 2.3% at the Sino-Guinean Friendship Hospital among patients receiving HIV and hepatitis B screening [13]. However, an estimated HIV/HBV co-infection seroprevalence of 16.9% was found in a study conducted in Benin in 2015 [17], which is close to our overall prevalence.

This high prevalence in our study could be explained by non-adherence to the treatment regimen, abandonment of antiretroviral treatment in favour of traditional treatment, and a lack of communication between spouses about their serological status. The results suggest that HIV/HBV co-infection requires special attention in the programme.

There were no significant differences in socio-demographic characteristics (age group, gender) or occupational characteristics (p-value˃0.05), which is similar to the results obtained in a survey conducted among university students in Nigeria [18] and among PLHIV at the Donka Day Hospital in Guinea [16].

The age group of co-infected patients is often between 30 and 50 years old. This age group, considered to be sexually active, is particularly affected by risky behaviours. Young adults may also face challenges related to education and awareness of healthy sexual practices, thus increasing their vulnerability to co-infection. The fact that this age group is the most affected highlights the need to strengthen prevention programmes specifically tailored to this group.

The results indicated that the majority of PLHIV co-infected with hepatitis B were women (21.4%). The overrepresentation of women in cases of co-infection could be linked to more frequent risk behaviours, such as unprotected sex, limited access to care and screening, female genital mutilation, which is an overlooked factor, and illiteracy. This observation is similar to the HIV/HBV co-infection study conducted in Central Africa, which found that women were more co-infected than men, at 70.9% [10].

In our study, unmarried individuals predominated over married individuals, with

However, several limitations must be taken into consideration.

The sample size may limit the applicability of the results to a larger population; the non-use of more sensitive diagnostic techniques such as ELISA and PCR. Future studies could benefit from a longitudinal methodology and a qualitative survey to explore the determinants of co-infection in greater depth.

5. Conclusion

This study highlighted the socio-professional profile of people living with Human Immunodeficiency Virus (HIV) and HBsAg-positive at Faranah Regional Hospital in 2022. The results indicate that the majority of participants were in the working age group and had a variety of occupations, which could suggest a significant public health concern. The socio-demographic characteristics observed showed disparities in factors such as marital status and occupation. These findings highlight the importance of education and awareness-raising. To strengthen public health efforts, it is important to develop tailored programmes that take into account the socio-professional realities of these individuals, incorporating multisectoral approaches that promote psychosocial support and improved living conditions. Collaboration between health authorities and community organisations is essential to improve early diagnosis, treatment and care for co-infected individuals.

Conflicts of Interest

The authors declare no conflicts of interest.

Authors' Consent

All authors declare that they have read and approved the final version of the manuscript.

References

[1]   | OMS 2024, Hépatite B https://www.who.int/fr/news-room/fact-sheets/detail/hepatitis-b. Consulté le 15.10.2024.
[2]   | Avila-Rios S, García-Morales C, Reyes-Terán G, González-Rodríguez A, Matías-Florentino M, Mehta SR, Chaillon A.2022.Phylodynamics of HIV in the Mexico City Metropolitan Region. J Virol96:e00708-22.
[3]   | Anteneh, Zelalem Alamrew, Estifanose Wondaye, and Endalkachew Worku Mengesha, ‘Hepatitis B Virus Infection and Its Determinants among HIV Positive Pregnant Women: Multicenter Unmatched Case-Control Study’, PloS One, 16.4 (2021), p. e0251084.
[4]   | Mossoro-Kpinde, C.D., Gbangba-Ngai, E., Mossoro-Kpinde, H.D., Camengo, Police, S.M., Kobangue, L., Selehina, E., Mbale, M. and Baïpo, F. (2016) Dépistage de l’antigene HBs chez les malades du VIH à Bangui. RevueBio-Africa, 15, 39-43.
[5]   | WHO (2016) Global Health Sector Strategy on Viral Hepatitis. WHO, Geneva. https:// www.who.int/ news-room/ fact-sheets/detail/hepatitis-b.
[6]   | Bonacci, M., Louie, S., Bzowej, N. and Wohl, A.R. (2004) Survival in Patients with HIV Infection and Viral Hepatitis B or C: A Cohort Study. AIDS, 18, Article ID: 203945.
[7]   | Alessandro R. Zanetti, Pierre Van Damme, and Daniel Shouval, ‘The Global Impact of Vaccination against Hepatitis B: A Historical Overview’, Vaccine, 26.49 (2008), pp. 6266–73.
[8]   | Keita, M, Fadiga AG, Soumah MM, Sylla D, Traore FA, Biané B, and others, ‘Co-Infection VIH et Virus de l’hépatite B Au Service d’hématologie de l’hôpital National Ignace Deen (Guinée-Conakry)’, Annales de Dermatologie et de Vénéréologie, 141.12 (2014), p. S442.

[9]  
Steve Leumi, Jean Joel Bigna, Marie A Amougou, Anderson Ngouo, Ulrich Flore Nyaga, Jean Jacques Noubiap, Global Burden of Hepatitis B Infection in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, Volume 71, Issue 11, 1 December 2020, Pages 2799–2806.

[10]   | Tékpa, G., Mossoro-Kpinde, H.D., Nazilari, J.G., Komoyo, G. and Diémer, S.C.H. (2024) Socio-Demographic and Occupational Aspects of HIVHBV Co-Infection in Bangui, Central African Republic (CAR): Hospital-Based Cross-Sectional Study. Advances in Infectious Diseases, 14, 310-321.
[11]   | Adrià Ramírez Mena, Ndeye Fatou Ngom, Judicaël Tine, Kine Ndiaye, Louise Fortes, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Daye Ka, Moussa Seydi, Gilles Wandeler, Prévalence et prédicteurs de la fibrose hépatique chez les personnes vivant avec l'hépatite B au Sénégal, Virus.

[12]  
M.S. Ouedraogo, S. Bara/Tiendrebeogo, P.G. Tapsoba, N. Korsaga/Some, A.N. Ouedraogo, L. Tiendrebeogo, A. Yameogo, F. Barro/Traoré, P. Niamba, A. Traoré. Coïnfection VIH/ Hépatite B et C chez les personnes vivant avec le VIH dans une structure associative de prise en charge médicale de la ville de Ouagadougou (BURKINA FASO) Annales de Dermatologie et de Vénéréologie, Volume 143, Numéro 4, Supplément 1, avril 2016, page S25.

[13]  
Makanera, Abdoulaye, Ignace Dramou, Sidikiba Sidibe, Mariam Conde, Ousmane Sy, Lansana Bomba Camara, and others, ‘Séroprévalence de La Co-Infection VIH /Virus de l’hépatite B à l’Hôpital de l’Amitié Sino-Guinéenne (HASIGUI) Kipé/Conakry (Guinée)’, Journal of Applied Biosciences, 135 (2019), pp. 13798–807.

[14]  
Camara, A., Thea, E., Haba, I., Youla, Y., Diallo, I., Diallo, M., Kaba, D., Camara, J., Condé, M., Soropogui, B., Kourouma, K., Tounkara, T., Mbengue, B., Touré, A. et Boumbaly, S. (2024) Séroprévalence du virus de l’immunodéficience humaine et de l’hépatite B chez les donneurs de sang au Centre régional de transfusion sanguine de N’Zérékoré en Guinée. Journal ouvert d’immunologie, 14, 33-45.

[15]   | Annuaire_INS_2019_opt. Pdf https:// www.statguinee.org/ images/ Documents/ Publications/ INS/ annuelles/ annuaire/ Annuaire_ INS_2019_opt.pdf.
[16]   | Kaba, D., Diallo, M. S., Barry, R., Diakite, M., Diane, B. F., Keita, F., … Cisse, M. (2020). Prévalence de l’Antigène HBS chez les Personnes Infectées par le VIH à l’Hôpital de Jour de Donka (Guinée). HEALTH SCIENCES AND DISEASE, 21(2).
[17]   | Comlan Albert Dovonou and others, ‘[Prevalence of hepatitis B in people infected with HIV in Parakou in Benin]’, The Pan African Medical Journal, 20 (2015), p. 125.
[18]   | Isa I, Aminu M, Abdullahi SA, Sani MA, Usman MA, Esona MD, Ella EE. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Infection among Students in Ahmadu Bello University, Zaria, Nigeria. Arch Med Biomed Res. 2017; 3(2): 77-90.